Globaldata
DATA · Main Market · Industrial Goods and Services · mcap £388m · 59.3p
GlobalData sells subscription data, analytics and research to companies in sectors such as healthcare, technology and finance. Most revenue is recurring and comes from annual contracts.
| Date | Type | Announcement | Day |
|---|---|---|---|
| 02 Oct 26 | Completion of Share Buyback Programme
GlobalData completed share buyback programme, repurchasing 6.7m shares at £5m total cost. |
−1.3% | |
|
Shares repurchased in programme 6,702,016Total cost £5mWeighted average price per share 59.4379pPrice range 58.20p - 60.70pOrdinary shares remaining in issue 705,528,818
|
|||
| 30 Sep 26 | Board change | Directorate Change
Graham Lilley stepped down as CFO and director; Rob Kingston appointed CFO and Board member. |
+2.1% |
| 14 Sep 26 | Results | Half-year Results
H1 revenue grew 4% to £162.9m but underlying growth of 1% fell short; FY26 guidance lowered to lower end of range. |
−18.7% |
|
towards the lower end of the range expectations Revenue £162.9m (£156.5m)Underlying revenue growth 1%Adjusted EBITDA £54.8m (£52.1m)Adjusted EBITDA margin 34% (33%)Adjusted basic EPS 2.7p (2.5p)Contracted Forward Revenue £163.3m (£157.4m)
|
|||
| 11 Aug 26 | Results | Results of Tender Offer and Total Voting Rights
Tender offer completed with 35.3m shares purchased for £30m at 85p per share. |
+0.1% |
|
Shares purchased 35,294,117Tender price 85p per shareTotal value returned £30 millionIssued share capital post-completion 709,105,053 sharesPercentage of capital tendered 4.73%
|
|||
| 06 Aug 26 | Result of General Meeting
Shareholders approve £30m share buy-back tender offer at 85 pence per share. |
+0.8% | |
|
Tender offer size £30mPrice per share 85 penceMaximum shares to buy back 35,294,117Votes for Resolution 586,424,999 (99.99%)Issued share capital 744,939,877 ordinary shares
|
|||
| 10 Jul 26 | Tender Offer
GlobalData launches £30m share buyback tender offer at 85 pence per share, a 16% premium to market price. |
+1.5% | |
|
Return of capital up to £30 millionShares to be purchased up to 35,294,117Tender price per share 85 pencePremium to closing mid-market price approximately 16 per centGuaranteed entitlement per shareholder approximately 4.73 per cent of holdingsDirectors' shareholdings supporting offer 454,731,188 shares (approximately 61 per cent of issued capital)
|
|||
| 09 Jul 26 | Trading update | Trading Update, Acquisition, Proposed Tender Offer
H1 2026 revenue growth 3% (1% underlying); £30m tender offer announced; Cambridge Healthcare acquired. |
−4.4% |
|
Revenue growth (reported) approximately 3%Underlying revenue growth approximately 1%Contracted Forward Revenue growth approximately 6%Adjusted EBITDA growth approximately 4-5%Tender offer £30 millionTotal capital returns for year £45m plus £8m carried over
|
|||
| 24 Jun 26 | Board change | Directorate Change
Robert Kingston appointed incoming CFO, to join 7 September 2026 and formally become board director 30 September 2026. |
−4.8% |
| 23 Jun 26 | Launch of new £5 million Share Buyback Programme
GlobalData launches £5 million share buyback programme to return surplus capital and reduce share capital. |
−2.9% | |
|
Buyback size £5 millionMaximum shares authorised for repurchase 75,721,663 Ordinary SharesMaximum price per share 105% of five-day average middle market quotationMinimum price per share £0.0001
|
|||
| 31 Mar 26 | Launch of new £10 million Share Buyback Programme
GlobalData launches £10 million share buyback programme to commence 31 March 2026 and complete before interim results. |
+9.4% | |
|
Share Buyback Programme £10 millionMaximum Ordinary Shares available for repurchase 80,653,410 sharesMaximum daily repurchase volume 25% of average daily volumeMaximum price per share 105% of five-day average middle market quotationMinimum price per share £0.0001
|
|||
| 05 Mar 26 | Admission to Main Market and AIM cancellation
GlobalData moved from AIM to Main Market listing on London Stock Exchange, cancelled from AIM. |
+6.2% | |
| 05 Mar 26 | Readmission - GLOBALDATA PLC
GlobalData ordinary shares cancelled from AIM trading. |
+6.2% | |
| 02 Mar 26 | Results | Final Results
FY25 revenue grew 13% to £322.1m, underlying growth 1%; Adjusted EBITDA fell 6% to £110.2m amid strategic investment. |
+0.0% |
|
Revenue £322.1m (£285.5m)Underlying revenue growth 1% (4%)Adjusted EBITDA £110.2m (£116.8m)Adjusted EBITDA margin 34% (41%)Profit before tax £69.2m (£54.9m)Contracted Forward Revenue £179.7m (£171.4m)
|
|||
| 10 Feb 26 | Board change | Directorate Change
Toby Walter appointed as independent non-executive director and Remuneration Committee chair, succeeding Annette Barnes. |
+1.1% |
| 04 Feb 26 | Update on Move to the Main Market
GlobalData to move from AIM to London Stock Exchange Main Market on 5 March 2026. |
−1.9% | |
| 19 Jan 26 | Board change | Directorate Change
Rachel Higham appointed as independent non-executive director; Annette Barnes and Andrew Day to step down. |
−2.1% |
| 14 Jan 26 | Trading update | Trading Update and Update on move to Main Market
FY25 revenue £322m up 13% reported, 1% organic; CFR up 6%; EBITDA £110m at 34% margins; moving to Main Market. |
−3.0% |
|
Revenue c.£322m (13% reported growth, 1% organic)Contracted Forward Revenue growth 6% (3% organic)Adjusted EBITDA c.£110m (34% margins)Net Debt c.£110mAvailable facility >£200mRevenue visibility for 2026 ~80%
|
|||
| 26 Nov 25 | Commencement of Share Buyback Programme
GlobalData commences £10 million share buyback programme, to be completed before next AGM. |
+0.0% | |
|
Maximum consideration £10 millionMaximum shares authorised for repurchase 80,653,410 Ordinary Shares
|
|||
| 24 Nov 25 | CME, Share Buyback & Update on Main Market Listing
GlobalData hosts Capital Markets Event, launches £10m share buyback, and updates on Main Market listing progress. |
+11.7% | |
|
Share buyback programme £10mTender Offer return to shareholders £60.0m (September 2025)Shares bought back in H1 £39.7m
|
|||
| 20 Oct 25 | Trading update | Trading Update and Capital Markets Event
Q3 revenue growth 13.5% with subscription acceleration, but H2 EBITDA margin guidance reduced to 37%. |
−3.7% |
|
in line expectations Q3 revenue growth 13.5%Underlying subscription revenue growth 2% (1% (H1 2025))Contracted Forward Revenue growth 4% (3% (H1 2025))H2 2025 Adjusted EBITDA margin guidance approximately 37%FY25 Adjusted EBITDA margin guidance approximately 35%FY25 Organic Margin approximately 38%
|
|||
| 25 Sep 25 | Update on proposed move to the Main Market
GlobalData confirms move to Main Market expected before end of 2025, with prospectus to follow. |
−4.8% | |
| 08 Sep 25 | Results | Results of Tender Offer and Total Voting Rights
Tender offer completed with 40m shares purchased at £1.50 per share for £60m total. |
−1.5% |
|
Shares purchased 40,000,000Tender price per share £1.50Total value returned £60 millionIssued share capital after completion 766,534,103 shares
|
|||
| 29 Aug 25 | Result of General Meeting
Shareholders approved a £60 million tender offer to buy back up to 40 million shares at £1.50 per share. |
+0.4% | |
|
Tender offer size £60mMaximum shares to buy back 40,000,000Buy-back price per share £1.50Votes for Resolution 623,245,554 (100.00%)Issued share capital 806,534,103 ordinary shares
|
|||
| 05 Aug 25 | Tender Offer and Notice of General Meeting
GlobalData proposes £60 million return of capital via tender offer at 150 pence per share, subject to shareholder approval. |
+0.0% | |
|
Return of capital up to £60 millionMaximum shares to be purchased 40,000,000Tender price per share £1.50Premium to closing mid-market price approximately 5.1%Closing mid-market price (Latest Practicable Date) 142.75 penceDirectors' shareholding backing 474,716,733 shares (approximately 58.9%)
|
|||
| 05 Aug 25 | Results | Half-year Results
H1 revenue grew 12% to £156.5m but underlying growth flat at 1%; Adjusted EBITDA margin fell to 33% from 41%. |
+0.0% |
|
Revenue £156.5m (£139.6m)Underlying revenue growth 1%Adjusted EBITDA £52.1m (£57.8m)Adjusted EBITDA margin 33% (41%)Operating profit £28.5m (£37.8m)Contracted Forward Revenue £157.4m (£142.9m)
|
|||
| 15 Jul 25 | Trading update | Trading Update
H1 revenue £157m, up 12% reported but flat organically; contracted forward revenue momentum building after slow Q1. |
−0.3% |
|
Revenue c.£157m (£140m)Revenue growth (reported) approximately 12%Organic revenue growth flatContracted Forward Revenue growth (organic, Q2) 3%Organic Adjusted EBITDA margin decline 3pptsTender offer up to £60 million at £1.50 per share
|
|||
| 11 Jun 25 | Offer | Statement re Possible Offer
ICG Europe Fund IX confirms it does not intend to make an offer for GlobalData. |
−10.1% |
| 11 Jun 25 | Offer Discussions Ended
GlobalData terminated takeover discussions with ICG Europe Fund IX regarding a proposed cash offer for the company. |
−10.1% | |
|
Target annualised revenue £500m
|
|||
| 28 May 25 | Rule 2.8 Announcement
KKR confirms it does not intend to make a firm offer for GlobalData following April announcement of possible offer. |
−1.6% | |
| 28 May 25 | Extension of Rule 2.6 Deadline
ICG deadline extended to 11 June 2025 to announce firm takeover bid; KKR talks terminated. |
−1.6% | |
| 13 May 25 | RNS Replacement
RNS announcement issued under incorrect company name; should have been under GB Group plc. |
+0.8% | |
| 02 May 25 | Suspension of Share Buyback Programme
GlobalData suspends share buyback programme following entry into offer period under takeover code. |
+0.5% | |
| 10 Mar 25 | Results | Final Results
FY24 revenue grew 5% to £285.5m with 41% EBITDA margin; targeting £500m revenue by end of 2026. |
−10.9% |
|
in line with market expectations expectations Revenue £285.5m (£273.1m)Adjusted EBITDA £116.8m (£110.8m)Profit before tax £54.9m (£41.5m)Adjusted EBITDA margin 41% (41%)Contracted Forward Revenue £171.4m (£153.4m)Net cash £10.1m ((£243.9m))
|
|||
| 06 Feb 25 | Proposed move to the Main Market
GlobalData proposes move to LSE Main Market, launches £50m share buyback, and extends Chairman tenure. |
+6.5% | |
|
Share Buyback Programme £50 millionPrevious buyback returns £30 million (completed 5 September 2024 and 13 January 2025)
|
|||
| 14 Jan 25 | Trading update | Trading Statement
FY24 revenue £286m in line with expectations; four acquisitions for £86m completed; net cash £2m after M&A spend. |
−2.9% |
|
in line expectations FY24 Revenue c.£286m (£273m)Underlying revenue growth 4%Adjusted EBITDA margin c.41% (41%)Contracted Forward Revenue growth 4%M&A transactions completed H2 4 deals for c.£86mNet cash c.£2m (Net debt £244m)
|
|||
| 07 Jan 25 | Acquisition of Deallus
GlobalData completed acquisition of Deallus, a life sciences competitive intelligence provider, on 31 December 2024. |
+3.0% | |
| 19 Dec 24 | New £340m debt financing facilities
GlobalData secures £340m new debt facilities maturing December 2027 to fund M&A strategy. |
+1.6% | |
|
Total new debt financing facilities £340mHealthcare business facility £176.6mGroup facility £163.4mHealthcare ACF £61.8mHealthcare RCF £114.8mMaturity date December 2027
|
|||
| 17 Dec 24 | Acquisition of Celent
GlobalData to acquire Celent, a research and advisory firm in financial services technology, expected to complete 31 December 2024. |
+0.0% | |
| 06 Dec 24 | Move to SETS trading platform
GlobalData transitions share trading from SETSqx to SETS platform on London Stock Exchange. |
−1.0% | |
| 13 Nov 24 | Trading update | Trading Update & LinkUp Acquisition
GlobalData completes acquisition of LinkUp, a global job market data provider, to support growth plan. |
+2.5% |
|
in line expectations |
|||
| 23 Sep 24 | Launch of Share Buyback Programme
Board approves £20 million share buyback programme, following previous £10 million programme completed in September. |
+0.5% | |
|
Share buyback programme £20 millionPrior buyback programme £10 million (completed 5 September 2024)Programme duration 23 September 2024 to 17 January 2025Maximum ordinary shares authorised to purchase 84,502,770
|
|||
| 06 Sep 24 | Completion of Share Buyback Programme
GlobalData completed £10m share buyback programme, purchasing 4,513,867 shares at average price of 221.5p. |
−3.7% | |
|
Total shares repurchased 4,513,867Total cost £10mVolume weighted average price 221.5pRemaining shares in issue 840,513,833
|
|||
| 30 Aug 24 | Update on Acquisition
GlobalData completed acquisition of Business Trade Media International Limited. |
+0.9% | |
| 21 Aug 24 | Result of General Meeting
General Meeting approved acquisition agreement with 100% of votes cast in favour. |
+0.0% | |
|
Votes in favour 684,769,063Votes against 19,694% in favour 100.00%Issued share capital (voting record) 843,058,898 ordinary shares
|
|||
| 16 Aug 24 | Update to Share Buyback Programme
GlobalData amends terms of £10m share buyback programme to allow purchases exceeding 25% of average daily volume. |
+1.4% | |
|
Capital return £10 million
|
|||
| 31 Jul 24 | Launch of Share Buyback Programme
Board approves £10 million share buyback programme to return surplus capital to shareholders. |
−0.9% | |
|
Capital return £10 millionMaximum ordinary shares to repurchase 84,502,770Programme period 31 July 2024 to 31 October 2024
|
|||
| 31 Jul 24 | Results | Half-year Results
Half-year revenue £139.6m, up 3% reported (5% underlying); Adjusted EBITDA £57.8m at 41% margin; Inflexion investment completed. |
−0.9% |
|
on track expectations Revenue £139.6m (£135.9m)Underlying revenue growth 5% (3%)Adjusted EBITDA £57.8m (£53.5m)Adjusted EBITDA margin 41% (39%)Profit before tax £26.9m (£23.9m)Net cash position £188.3m ((£230.8m) net debt)
|
|||
| 05 Jun 24 | Update re. Inflexion minority stake investment
Inflexion investment in Healthcare division to complete on 28 June 2024, yielding net cash proceeds of £434 million. |
+1.4% | |
|
Net cash proceeds from Inflexion investment £434 million
|
|||
| 02 May 24 | Appointment of Joint Broker
Investec appointed as Joint Broker alongside existing brokers J.P. Morgan Cazenove and Panmure Gordon. |
+4.7% | |
| 23 Apr 24 | Result of AGM
All resolutions passed at AGM with high shareholder support; final dividend of 3.2p approved. |
+0.7% | |
| 27 Mar 24 | Results | Annual Report for year ended 31 December 2023
Annual Report for year ended 31 December 2023 now available on company website. |
+0.5% |
| 04 Mar 24 | Results | Final Results
FY23 revenue grew 12% to £273.1m with Adjusted EBITDA margin reaching 41%. Inflexion to acquire 40% of Healthcare division for £434m. |
−3.4% |
|
Revenue £273.1m (£243.2m)Adjusted EBITDA £110.8m (£86.4m)Adjusted EBITDA margin 41% (36%)Statutory profit before tax £41.5m (£38.4m)Total dividends 4.6p (3.6p)Inflexion Healthcare stake proceeds £434m
|
|||
| 24 Jan 24 | Investor and Analyst Seminar
GlobalData to host investor seminar on new growth strategy and customer-focused divisions. |
+0.0% | |
| 11 Jan 24 | Trading update | Trading Update & Announcement of Investor Seminar
FY2023 revenue £273m, up 12%, adjusted EBITDA £111m, up 28%. Healthcare minority stake sale to complete Q2 2024. |
−2.8% |
|
within range of market expectations expectations FY2023 Revenue £273m (£243m)Revenue growth 12% (7% underlying)Adjusted EBITDA £111m (£86m)EBITDA growth 28%EBITDA margin 41% (36%)Healthcare stake valuation £1,115m
|
|||
| 21 Dec 23 | Investment in Healthcare Division by Inflexion
Inflexion acquires 40% stake in Healthcare division at £1,115m valuation; GlobalData receives £434m net cash proceeds. |
+20.9% | |
|
Healthcare division valuation £1,115mInflexion shareholding 40%Net cash proceeds to GlobalData £434mHealthcare division LTM EBITDA (June 2023) £50mMultiple on Healthcare EBITDA 22xExpected balance sheet outcome Net cash, debt-free
|
|||
Company filings. Not investment advice.